IP6K2
Inositol hexakisphosphate kinase 2
Also known as: IHPK2, IP6K2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHH9
- Gene
- IP6K2
- Ensembl
- ENSG00000068745
- Chromosome
- 3
- Canonical length
- 426 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Cell Junctions
OverviewNCBI Gene
This gene encodes a protein that belongs to the inositol phosphokinase (IPK) family. This protein is likely responsible for the conversion of inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). It may also convert 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4 and affect the growth suppressive and apoptotic activities of interferon-beta in some ovarian cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
426 residues, UniProt reviewed canonical sequence.
>Q9UHH9|IP6K2
1 MSPAFRAMDV EPRAKGVLLE PFVHQVGGHS CVLRFNETTL CKPLVPREHQ FYETLPAEMR
61 KFTPQYKGVV SVRFEEDEDR NLCLIAYPLK GDHGIVDIVD NSDCEPKSKL LRWTTNKKHH
121 VLETEKTPKD WVRQHRKEEK MKSHKLEEEF EWLKKSEVLY YTVEKKGNIS SQLKHYNPWS
181 MKCHQQQLQR MKENAKHRNQ YKFILLENLT SRYEVPCVLD LKMGTRQHGD DASEEKAANQ
241 IRKCQQSTSA VIGVRVCGMQ VYQAGSGQLM FMNKYHGRKL SVQGFKEALF QFFHNGRYLR
301 RELLGPVLKK LTELKAVLER QESYRFYSSS LLVIYDGKER PEVVLDSDAE DLEDLSEESA
361 DESAGAYAYK PIGASSVDVR MIDFAHTTCR LYGEDTVVHE GQDAGYIFGL QSLIDIVTEI
421 SEESGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against IP6K2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 166 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 166 nTPM
- skin: 141 nTPM
- bone marrow: 123 nTPM
- pituitary gland: 117 nTPM
- cervix: 111 nTPM
- prostate: 108 nTPM
Single-cell type
- colonocytes: 225 nCPM
- goblet cells: 196 nCPM
- epididymal principal cells: 194 nCPM
- syncytiotrophoblasts: 188 nCPM
- cytotrophoblasts: 177 nCPM
- extravillous trophoblasts: 177 nCPM
Immune cell
- basophil: 159 nTPM
- eosinophil: 93 nTPM
- T-reg: 84 nTPM
- neutrophil: 81 nTPM
- NK-cell: 69 nTPM
- non-classical monocyte: 66 nTPM
Brain region
- cerebellum: 122 nTPM
- white matter: 77 nTPM
- hypothalamus: 67 nTPM
- cerebral cortex: 66 nTPM
- basal ganglia: 65 nTPM
- pons: 63 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.63
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- inositol phosphate biosynthetic process
- inositol phosphate metabolic process
- negative regulation of cell growth
- phosphatidylinositol phosphate biosynthetic process
- positive regulation of apoptotic process
- positive regulation of protein K48-linked ubiquitination
- protein stabilization
- cellular response to flavonoid
Molecular functions
- ATP binding
- diphosphoinositol pentakisphosphate kinase activity
- diphosphoinositol tetrakisphosphate kinase activity
- flavonoid binding
- inositol 5-diphosphate pentakisphosphate 5-kinase activity
- inositol hexakisphosphate 5-kinase activity
- inositol hexakisphosphate kinase activity
- inositol-1,3,4,5,6-pentakisphosphate kinase activity
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IP6K2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IP6K2 as an antibody target. Whether an autoantibody or antibody against IP6K2 could matter depends on whether native IP6K2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IP6K2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IP6K2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...